Peptide Ligand of the Epidermal Growth Factor Receptor for Sensitizing Lung Cancer Cells to Gefitinib

被引：0
|
作者：
ALHamar, Zahrah Ali [1 ]
Andey, Terrick [1 ]
机构：
[1] MCPHS, Pharmacol, Worcester, MA USA
来源：
FASEB JOURNAL | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
671.2
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib
    Zhang, Xiang
    Nagahara, Hisashi
    Mimori, Koshi
    Inoue, Hiroshi
    Sawada, Tetsuji
    Ohira, Masaichi
    Hirakawa, Kosei
    Mori, Masaki
    [J]. ONCOLOGY REPORTS, 2008, 19 (06) : 1541 - 1544
  • [32] Clinical usefulness of gefitinib for non-small-cell lung cancer with a double epidermal growth factor receptor mutation
    Oikawa, Takefumi
    Ohira, Tatsuo
    Otani, Keishi
    Hagiwara, Masaru
    Konaka, Chimori
    Ikeda, Norihiko
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 329 - 333
  • [33] Case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib
    Schwab, R
    Pinter, F
    Moldavy, J
    Papay, J
    Strausz, J
    Kopper, L
    Keri, G
    Pap, A
    Petak, I
    Oreskovich, K
    Mangel, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) : 7736 - 7738
  • [34] Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese
    Uramoto, H
    Sugio, K
    Oyama, T
    Ono, K
    Sugaya, M
    Yoshimatsu, T
    Hanagiri, T
    Morita, M
    Yasumoto, K
    [J]. LUNG CANCER, 2006, 51 (01) : 71 - 77
  • [35] Formation of Gefitinib-Resistant Lung Cancer Cell Lines and their Changes in Epidermal Growth Factor Receptor Signaling Pathway
    Song, Yunxi
    Ma, Jianxin
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 (05) : 1269 - 1278
  • [36] Impact of epidermal growth factor receptor gene status on gefitinib treated non-small-cell lung cancer
    Ichihara, Shuji
    Toyooka, Shinichi
    Tokumo, Masaki
    Kiura, Katsuyuki
    Fujiwara, Yoshiroh
    Shigematsu, Hisayuki
    Hotta, Katsuyuki
    Asano, Hiroaki
    Ichimura, Kouichi
    Aoe, Keisuke
    Aoe, Motoi
    Sano, Yoshifumi
    Date, Hiroshi
    Shimizu, Nobuyoshi
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [37] Gefitinib for epidermal growth factor receptor mutant lung cancers:: Searching for a weapon of mass destruction
    Jaenne, Pasi A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) : 3319 - 3321
  • [38] MUTATION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE AND EFFICACY OF GEFITINIB IN SQUAMOUS CELL CARCINOMA OF LUNG
    Miwa, Toshiro
    Kashii, Tatsuhiko
    Suzuki, Kensuke
    Inomata, Minehiko
    Tsuda, Takeshi
    Tokui, Kotaro
    Taka, Chihiro
    Okazawa, Seisuke
    Kanbara, Kenta
    Yamada, Toru
    Hayashi, Ryuji
    Matsui, Shoko
    Toge, Masayoshi
    Senda, Kazutaka
    Doki, Yoshinori
    Nomura, Kuninori
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S872 - S872
  • [39] Epidermal growth factor receptor as a therapeutic target in lung cancer
    Schiller, JH
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 25 : 11 - 16
  • [40] Epidermal growth factor receptor family in lung cancer and premalignancy
    Franklin, WA
    Veve, R
    Hirsch, FR
    Helfrich, BA
    Bunn, PA
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (01) : 3 - 14
12345